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ABSTRACT
Objective: The aim of this study is to identify the 
rectovaginal GBS colonization rate in pregnant 
women in our hospital and to evaluate the 
outcome of culture positive patients who had 
received intrapartum antibiotic prophylaxis (IAP) 
according to the protocol of The American 
Academy of Pediatrics.
Methods: One hundred pregnant women 
followed at the Obstetrics outpatient clinic of 
Marmara University Hospital were screened at 
35-37 weeks for rectovaginal group B 
streptococcus (GBS) colonization. The patients 
with risk factors or positive cultures were treated 
with parenteral ampicillin during the intrapartum 
period and the newborn of mothers who had 
received antibiotic prophylaxis were followed.
Results: Ten patients (10%) had rectovaginal 
colonization whereas 1 patient had urinary tract 
infection secondary to GBS. All but 2 patients 
with GBS colonization received intrapartum 
antibiotic prophylaxis; one of the GBS colonized 
patients had immediate cesarean section
delivery for fetal distress and could not receive 
intrapartum antibiotic prophylaxis, the culture 
result of the other patient was not known during 
labor so she could not receive intrapartum 
antibiotic prophylaxis. The newborn of the GBS 
(+) patient who had immediate C/S, developed 
early onset sepsis, GBS antigen was detected in 
his urine and this newborn was treated with 
intravenous antibiotics, inotropic agents and 
needed ventilatory support.
The second infant with GBS colonized but not 
appropriately treated mother did not have any 
problems. The newborn of the GBS (+) patients 
whose mothers had received intrapartum 
antibiotic prophylaxis were discharged without 
any complications.
Conclusion: The rectovaginal GBS colonization 
rate in pregnant women is 10% in our hospital, 
which cannot be despised. Larger multicenter 
screening programs are needed to assess the 
prevalence of GBS colonization and the efficacy 
of intrapartum antibiotic prophylaxis in our 
country.
(Accepted 7 February, 2001) Marmara Medical Journal 2001 ;14(2):79-83
Correspondance to: Eren Özek, M.D. -  e.mail address: mozek@türk.net
7 9
İpek Akman, et al
K e y  W o r d s :  Pregnancy, Group B cultures were treated with parenteral ampicillln at
streptococcus infections, Antibiotic prophylaxis. a dose of 1 gr every 4 hours until delivery. (Fig. 1)
IN TR O D U C TIO N
Perinatal group B streptococcal (GBS) infection 
is a significant, yet largely preventable, public 
health problem. It is significant, because It 
continues to be a major cause of serious 
infections in pregnant women, fetuses, newborn 
and immunocompromised patients (1). It is 
largely preventable, because intrapartum 
chemoprophylaxis for maternal carriers interrupts 
vertical transmission (2). Estimates of the most 
serious infection, neonatal early-onset group B 
streptococcal disease, vary between 1-4 per 
1000 live births in USA and Western Europe (3). 
The risk of group B streptococcus sepsis in a 
newborn increases if the mother has rectovaginal 
colonization. The transmission rate of infection to 
the fetus is higher in preterm labor, prolonged 
rupture of membranes and maternal intrapartum 
fever (3).
The American Academy of Pediatrics Committee 
on Fetus and Newborn recommends routine 
antenatal screening of all pregnant women and 
intrapartum chemoprophylaxis to colonized 
patients (4). The aim of this study is to identify the 
frequency of rectovaginal colonization of GBS in 
pregnant women in our hospital and to evaluate 
the outcome of culture positive patients who had 
received intrapartum antibiotic prophylaxis (IAP) 
according to the protocol of The American 
Academy of Pediatrics.
M ATERIALS A N D  M E T H O D S
In our study 100 pregnant women between 18-41 
years of age followed at Marmara University 
Hospital, Obstetrics and Gynecology outpatient 
clinic between January 1999 and June 1999 
were screened for rectovaginal GBS 
colonization. Informed consent was obtained 
from the patients before the study. Rectovaginal 
samples which were obtained at 35-37 th weeks 
of gestation were placed in a transport medium 
(Amies) then processed in a selective culture 
media containing nalidixic acid (15 pg/ml) and 
gentamicin (8 pg/ml). During the intrapartum 
period, patients with risk factors or positive
The newborn of mothers who had received 
antibiotic prophylaxis were followed according to 
Figure II. All pregnant women and their babies 
were evaluated for complications such as 
preterm labor, prolonged rupture of membranes 
and maternal intrapartum fever or neonatal 
infections.
yes ,  ___  Give intrapartum penicillin
GBS (+)
| Offer intrapartum penicillin
yes |----------------------------------------------------
------------► Give intrapartum penicillin**
No intrapartum prophylaxis
no prophylaxis is needed if culture result at 35 to 37 weeks is known to be 
negative.
broad spectrum antibiotics m ay be considered at the discretion of the physician 
based on clinical indications.
no
Fig.l : Prevention strategy for early - onset GBS disease 
using prenatal culture screening at 35 to 37 weeks 
gestation.
Fig.2 : Suggested approach for the management of the 
newborn of mothers with IAP.
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Statistical Analysis
Maternal age, gestational age at delivery and 
birthweight of the offspring of GBS colonized 
women were compared to those of women 
without GBS colonization by student's t test. The 
parity and mode of delivery of the two groups 
were compared by Fisher's exact test.
RESULTS
The patient population consisted of 100 pregnant 
women between 18 to 41 years of age. Age, 
parity, mode of delivery, birthweight and 
incidence of maternal or fetal infections were not 
significantly different between the culture positive 
and negative patients (Table I) (p>0.05). There 
were no multiple pregnancies, preterm or 
postterm deliveries. Ten patients (10%) had 
rectovaginal GBS colonization whereas 1 patient 
had urinary tract infection secordary to GBS. The 
multipar patients had not had any infectious 
complications in their previous pregnancies. All 
but 2 patients with GBS colonization received 
intrapartum antibiotic prophylaxis as well as 
treatment of urinary tract infection when present. 
One of the GBS colonized patients had 
immediate cesarean section delivery for fetal 
distress and could not receive intrapartum 
antibiotic prophylaxis. The culture result of the
other patient was not known during labor so she 
could not receive intrapartum antibiotic 
prophylaxis as well. In both groups there were no 
complications of pregnancy, labor or delivery 
such as premature rupture of membranes or 
maternal infection (Table I).
The newborn of the GBS (+) patient who had 
fetal distress and could not receive intrapartum 
antibiotic prophylaxis developed clinical 
symptoms of sepsis and had full diagnostic 
evaluation (Fig. 2). Empirical antibiotics were 
started after cultures were obtained. The urine 
sample was positive for GBS antigen but blood, 
urine and cerebrospinal fluid cultures were 
negative. This newborn was treated with 
intravenous antibiotics, inotropic agents and 
needed ventilatory support for 4 days. Although 
the cultures were negative, the antibiotic 
treatment was continued for 10 days because of 
the critical condition of the patient. At the end of 
the treatment the infant was discharged without 
any complications. The second infant with GBS 
colonized but not appropriately treated mother 
did not have any problems. The other newborn of 
the GBS (+) patients whose mothers had 
received more than two doses of intrapartum 
antibiotic prophylaxis were observed for 48 hours 
and discharged without any complications.
Table I.: P atien ts ' cha rac te ris tics .
GBS (•) 
(n=90)
GBS (+) 
(n=10) p
AGE (years) 28.29 ±5.28 26.0 ± 6.21 0,24
PARITY (n) PRIMIPAR
MULTIPAR
39 (43%) 
51 (57%)
4 (40%) 
6 (60%)
0,45
GESTATIONAL AGE (weeks) 39.21 ± 1.03 39.0 ±1.41 0,14
MODE OF 
DELIVERY
VAGINAL
DELIVERY
69 (77%) 6 (60%) 0,11
n (%) C/S 21 (33%) 4 (40%)
BIRTHWEIGHT (grams) 3279 ± 362 2884 ± 526 0,09
PROM* (n) - -
MATERNAL INFECTION (n) - -
NEONATAL INFECTION (n) - r *
* PROM: Prolonged rupture ot membranes
**  The mother of this infant could not receive intrapartum antibiotic prophylaxis.
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D IS C U S S IO N
The maternal genital and gastrointestinal tracts 
are the principal sources of GBS organisms 
leading to both maternal and neonatal infection. 
Studies conducted in previous decades reported 
that the factors influencing GBS colonization 
were maternal age, socioeconomic status, sexual 
activity, ethnic origin or mode of contraception 
(intrauterine device etc.) before pregnancy (3,5). 
Recent reports indicate GBS colonization rates 
in pregnant women to be 8-40 % and 50-75 % of 
their infants become colonized but only about 2% 
acquire early onset GBS disease (3,6-9). Direct 
comparisons of the prevalence of colonization 
reported in the literature are virtually impossible 
because of the differences in culture techniques 
employed for study. Gokalp et al have reported 
that the colonization rate of Turkish women is
8.1 % (9). In our study colonization was detected 
in 10% of 100 mothers and was not influenced by 
maternal age, parity, mode of delivery or 
gestational age at delivery.
Several factors influence the accuracy of 
detecting colonization in a given population, 
including: the choice of bactériologie media, the 
body sites sampled, the number of cultures 
obtained. The importance of optimal sample 
collection and adequate microbiologie technique 
in determining GBS colonization cannot be 
underestimated. Gardner et al have shown that 
20 % of colonized women will be missed if 
samples are not collected from both the vaginal 
orifice and rectum (10). Similarly, Silver et al 
have reported that 31.9 % of patients with GBS 
colonization will not show any growth in their 
cultures if selective culture medium is not used
(11). In this study both rectal and vaginal cultures 
were collected using "Amies" transport medium 
and the samples were transferred to a selective 
culture medium as soon as possible.
There is ample evidence to support the efficacy 
of intrapartum chemoprophylaxis in the 
prevention of neonatal GBS colonization and 
early onset disease (2). Several protocols have 
been suggested for management of colonized 
pregnant women. The most effective of all in 
preventing neonatal infections is the use of 
intrapartum chemoprophylaxis for both colonized 
women detected at prenatal screening and 
women with risk factors (4). Several maternal
and neonatal factors (maternal GBS colonization, 
maternal urinary tract infection (GBS), or 
intrapartum fever, premature delivery or 
prolonged rupture of membranes) increase the 
risk of infection (4,12). On the other hand 
intrapartum antibiotic prophylaxis significantly 
decreases the risk of infection. 
Chemoprophylaxis should start at least 4 hours 
prior to delivery to achieve therapeutic 
concentrations in the amniotic fluid. Thus 
intrapartum prophylaxis should be started as 
soon as the patient presents for delivery. Oral 
antibiotics used prior to delivery cannot prevent 
colonizations (4). Routine prenatal screening at 
35-37 weeks of gestation and using intrapartum 
antibiotic prophylaxis when needed will prevent 
86% of all GBS infections (4,13).
GBS infection is thought to be rare in 
nonindustrialized countries, although this may be 
changing, similar maternal colonization rates are 
reported in the literature from developing 
countries (9). This study also shows that the GBS 
colonization rates of pregnant women in our 
hospital is within the ranges reported in the 
literature. Though we need larger multicenter 
studies to define the prevalence of GBS 
colonization and infection, it seems reasonable 
not to underestimate the GBS problems in our 
country.
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